Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 5, 2007

LGC to Market Human Genomic Reference Controls in India and Europe

  • LGC Promochem entered into an agreement with Gentris for the marketing and distribution of GentriSure range of Human Genomic Reference Controls (HGRC) in Europe and India.

    The GentriSure products offer highly characterized controls for a variety of key genetic polymorphisms. Currently available controls contain polymorphisms for CYP2D6, CYP2C19, CYP2C9, and VKORC1 genes.

    The controls are isolated from B-lymphoblastoids derived from individual donors. DNA sequences are verified using bi-directional sequencing. There are no artificial DNA sequences introduced to the cell lines so the controls are virtually identical to genomic DNA isolated from typical patient samples.



Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »